Citadel Advisors’s Cumberland Pharmaceuticals CPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $249K | Buy |
74,406
+48,592
| +188% | +$163K | ﹤0.01% | 4800 |
|
|
2025
Q1 | $109K | Buy |
+25,814
| New | +$109K | ﹤0.01% | 5121 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 6094 |
|
|
2024
Q3 | – | Sell |
-834
| Closed | -$1.28K | – | 5906 |
|
|
2024
Q2 | $1.28K | Sell |
834
-2,788
| -77% | -$4.27K | ﹤0.01% | 5696 |
|
|
2024
Q1 | $6.09K | Buy |
3,622
+87
| +2% | +$146 | ﹤0.01% | 5743 |
|
|
2023
Q4 | $6.15K | Sell |
3,535
-2,398
| -40% | -$4.17K | ﹤0.01% | 5591 |
|
|
2023
Q3 | $11.2K | Sell |
5,933
-13,776
| -70% | -$26K | ﹤0.01% | 5419 |
|
|
2023
Q2 | $29K | Sell |
19,709
-1,624
| -8% | -$2.39K | ﹤0.01% | 5158 |
|
|
2023
Q1 | $41.6K | Sell |
21,333
-7,789
| -27% | -$15.2K | ﹤0.01% | 5220 |
|
|
2022
Q4 | $65.5K | Buy |
+29,122
| New | +$65.5K | ﹤0.01% | 5181 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 5984 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 6107 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 6448 |
|
|
2021
Q4 | – | Sell |
-12,021
| Closed | -$32K | – | 6534 |
|
|
2021
Q3 | $32K | Buy |
+12,021
| New | +$32K | ﹤0.01% | 6224 |
|
|
2021
Q2 | – | Sell |
-17,005
| Closed | -$52K | – | 6471 |
|
|
2021
Q1 | $52K | Buy |
+17,005
| New | +$52K | ﹤0.01% | 6089 |
|
|
2016
Q3 | – | Sell |
-12,895
| Closed | -$58K | – | 3619 |
|
|
2016
Q2 | $58K | Buy |
12,895
+1,671
| +15% | +$7.52K | ﹤0.01% | 3041 |
|
|
2016
Q1 | $50K | Buy |
+11,224
| New | +$50K | ﹤0.01% | 3001 |
|
|
2014
Q2 | – | Sell |
-14,475
| Closed | -$65K | – | 3481 |
|
|
2014
Q1 | $65K | Buy |
+14,475
| New | +$65K | ﹤0.01% | 3192 |
|
|
2013
Q3 | – | Sell |
-38,959
| Closed | -$199K | – | 2962 |
|
|
2013
Q2 | $199K | Buy |
+38,959
| New | +$199K | ﹤0.01% | 2267 |
|